Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

New cooling device used for first time to terminate AFib | CCTA shows colchicine's impact | Heart health in US getting worse

News You Need to Know Today
New cooling device used for first time to terminate AFib | CCTA shows colchicine's impact | Heart health in US getting worse
Friday, May 9, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks. 

READ MORE >
heart ice cool cold freezing frozen
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

Share on Twitter Share on Facebook Share on Linkedin
heart ice cool cold freezing frozen
Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks. 
READ MORE >

AI-enabled CCTA evaluations reduce use of invasive imaging exams

This two-year analysis of the FISH&CHIPS study found that using advanced AI from Heartflow to evaluate cardiac CT is safe, effective and limits the use of unnecessary follow-up tests.

READ MORE >
An example of HeartFlow's FFR-CT technology, which takes the cardiac CT dataset and uses computational fluid dynamics to create virtual fraction flow reserve values. The FFR measurement can help determine if a coronary lesion is significant enough to require revascularization, or if the patient should be treated with medication. FFR-CT was included as a recommendation in select patients in the 2021 Chest Pain Guidelines.
Share on Twitter Share on Facebook Share on Linkedin

AI-enabled CCTA evaluations reduce use of invasive imaging exams

Share on Twitter Share on Facebook Share on Linkedin
An example of HeartFlow's FFR-CT technology, which takes the cardiac CT dataset and uses computational fluid dynamics to create virtual fraction flow reserve values. The FFR measurement can help determine if a coronary lesion is significant enough to require revascularization, or if the patient should be treated with medication. FFR-CT was included as a recommendation in select patients in the 2021 Chest Pain Guidelines.
This two-year analysis of the FISH&CHIPS study found that using advanced AI from Heartflow to evaluate cardiac CT is safe, effective and limits the use of unnecessary follow-up tests.
READ MORE >

CCTA shows colchicine's impact on atherosclerosis progression

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

READ MORE >
Matthew Budoff explains use of CCTA to track coronary disease plaque progression
Share on Twitter Share on Facebook Share on Linkedin

CCTA shows colchicine's impact on atherosclerosis progression

Share on Twitter Share on Facebook Share on Linkedin
Matthew Budoff explains use of CCTA to track coronary disease plaque progression
Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.
READ MORE >

Rates of obesity, high blood pressure and diabetes keep climbing in US

As time goes on, the gaps between the healthiest states and the least healthy states are only getting wider and wider. "Our findings highlight the urgent need for targeted strategies to reduce state-based inequities in cardiometabolic risk factors,” researchers wrote. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Rates of obesity, high blood pressure and diabetes keep climbing in US

Share on Twitter Share on Facebook Share on Linkedin
As time goes on, the gaps between the healthiest states and the least healthy states are only getting wider and wider. "Our findings highlight the urgent need for targeted strategies to reduce state-based inequities in cardiometabolic risk factors,” researchers wrote. 
READ MORE >

Featured Articles

Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients

The approval of certain TAVR valves to be used in asymptomatic patients is expected to make a significant impact on patient care going forward. 

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
The approval of certain TAVR valves to be used in asymptomatic patients is expected to make a significant impact on patient care going forward. 
READ MORE >

High Lp(a) levels increase risk of repeat cardiovascular events—LDL drugs may help

Researchers evaluated data from more than 273,000 patients with a history of ASCVD, noting that higher Lp(a) levels are consistently linked to worse cardiovascular outcomes.

READ MORE >
The Society of Cardiovascular Computed Tomography developed and published the new document to help educate healthcare providers who regularly treat acute chest pain in the emergency department (ED). 
Share on Twitter Share on Facebook Share on Linkedin

High Lp(a) levels increase risk of repeat cardiovascular events—LDL drugs may help

Share on Twitter Share on Facebook Share on Linkedin
The Society of Cardiovascular Computed Tomography developed and published the new document to help educate healthcare providers who regularly treat acute chest pain in the emergency department (ED). 
Researchers evaluated data from more than 273,000 patients with a history of ASCVD, noting that higher Lp(a) levels are consistently linked to worse cardiovascular outcomes.
READ MORE >

In Case You Missed It

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns

The devices are being recalled and discontinued after the FDA shared a series of concerns. This is a Class I recall, meaning using this system could result in serious injuries or death.

READ MORE >
Q’Apel Medical 072 Aspiration System
Share on Twitter Share on Facebook Share on Linkedin

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns

Share on Twitter Share on Facebook Share on Linkedin
Q’Apel Medical 072 Aspiration System
The devices are being recalled and discontinued after the FDA shared a series of concerns. This is a Class I recall, meaning using this system could result in serious injuries or death.
READ MORE >

Atrial Fibrillation Centers of Excellence: The best path forward for high-quality care and better outcomes

The world is in the throes of an AFib pandemic, one that could potentially get worse in the years ahead due to population growth, economic hardships and rigid resource limitations. According to the Heart Rhythm Society, one way to effectively combat this issue is the development of more AFib Centers of Excellence.

READ MORE >
Heart cardiologists doctors surgery
Share on Twitter Share on Facebook Share on Linkedin

Atrial Fibrillation Centers of Excellence: The best path forward for high-quality care and better outcomes

Share on Twitter Share on Facebook Share on Linkedin
Heart cardiologists doctors surgery
The world is in the throes of an AFib pandemic, one that could potentially get worse in the years ahead due to population growth, economic hardships and rigid resource limitations. According to the Heart Rhythm Society, one way to effectively combat this issue is the development of more AFib Centers of Excellence.
READ MORE >

Underweight TAVR patients face higher mortality risk—obesity makes no significant impact

Reviewing data from more than 6,000 patients, researchers found little evidence of the "obesity paradox" observed elsewhere. Underweight TAVR patients, however, may face some significant long-term risks.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Underweight TAVR patients face higher mortality risk—obesity makes no significant impact

Share on Twitter Share on Facebook Share on Linkedin
Reviewing data from more than 6,000 patients, researchers found little evidence of the "obesity paradox" observed elsewhere. Underweight TAVR patients, however, may face some significant long-term risks.
READ MORE >

In Other News

Oklahoma governor vetoes bill requiring coverage for supplemental breast imaging

"This legislation imposes new and costly insurance mandates on private health plans that will ultimately raise insurance premiums for working families and small businesses," said Gov. J. Kevin Stitt. 

READ MORE >
Oklahoma Governor J. Kevin Stitt
Share on Twitter Share on Facebook Share on Linkedin

Oklahoma governor vetoes bill requiring coverage for supplemental breast imaging

Share on Twitter Share on Facebook Share on Linkedin
Oklahoma Governor J. Kevin Stitt
"This legislation imposes new and costly insurance mandates on private health plans that will ultimately raise insurance premiums for working families and small businesses," said Gov. J. Kevin Stitt. 
READ MORE >

Report: Former TV writer exploiting ACA to sell bare-bones insurance plans

Bloomberg writes about a company, Quick Health, run by a former comedy writer, who through a loophole in the law is accused of "hiring" members for fake jobs to enroll them in junk insurance policies.

READ MORE >
TV
Share on Twitter Share on Facebook Share on Linkedin

Report: Former TV writer exploiting ACA to sell bare-bones insurance plans

Share on Twitter Share on Facebook Share on Linkedin
TV
Bloomberg writes about a company, Quick Health, run by a former comedy writer, who through a loophole in the law is accused of "hiring" members for fake jobs to enroll them in junk insurance policies.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI
New FFR-CT standardization consensus document | FDA clears first tricupid surgical valve | ECG AI to detect amyloidosis
Shockwave Medical's new IVL catheter | BATMAN to the rescue | Antiplatelet drugs after PCI | FDA announces recalls
When TAVR patients require surgery later in life | Colleagues pay tribute to a cardiology powerhouse | Much more
TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant
Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Current page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup